期刊文献+

胶质母细胞瘤染色体1p36杂合性缺失的初步研究

A Primary Study of Loss of Heterozygosity on Chromosome 1p36 in Glioblastomas
下载PDF
导出
摘要 目的探讨1p36上可能存在的与胶质母细胞瘤(GBM)发生有关的肿瘤抑制基因的缺失区域,为发现和定位肿瘤抑制基因提供线索和依据。方法运用聚合酶链反应(PCR)技术为基础的杂合性缺失分析(LOH)法对12例胶质母细胞瘤染色体1p36上12个微卫星多态标记序列作了较详细研究。结果12例胶质母细胞瘤至少有一个位点出现杂合性缺失者11例,总缺失率为91.7%(11/12),其中以D1S214-D1S2666位点间区域LOH的频率最高。结论胶质母细胞瘤染色体1p36发生高频率杂合性缺失,提示位点D1S214-D1S2666缺失区域间可能存在着与GBM发生有关的抑癌基因。 Objective The study of loss of heterozygosity(LOH) was performed to locate the deletion areas probably harboring tumor suppressor genes and provide clues for discovering tumor suppressor genes. Methods Twelve polymorphie mierosatellite markers on chromosome 1p36 in 12 eases of glioblastomas were analyzed to detect LOH by PCR based techniques. Results 91.7% informative eases of Glioblastomas displayed LOH on 1 p36. The most frequent LOH were observed at loci from D1S214 to D1S2666 on 1p36. Conclusion The highly frequent LOH was observed on chromosome 1 p36 in human Glioblastomas. The results of this study indicate that the chromosomal regions at loci from D1 S214 to D1 S2666 on 1p36 may contain tumor suppressor genes associated with the origin of Glioblastomas.
出处 《潍坊医学院学报》 2008年第3期230-232,共3页 Acta Academiae Medicinae Weifang
关键词 胶质母细胞瘤 1p36 杂合性缺失 抑癌基因 Glioblastomas 1 p36 Loss of heterozygosity Tumor suppressor genes
  • 相关文献

参考文献13

  • 1Tetsuga S, Kazuo T. Alterations of human brain tumors as molecular prognostic factors [ J ]. Neuropathology ,2003 ,23 ( 1 ) :95 - 108.
  • 2Gaspar JK, Kristen LT, Robert BJ. Recent advances in the Molecular genetics of primary gliomas[ J]. Curr Opin Oncol,2003,15 ( 3 ) : 177 - 203.
  • 3徐从高 张茂宏 杨兴季.癌-肿瘤学原理和实践[M].济南:山东科学技术出版社,2001.254.
  • 4Lazo PA. The molecular genetics of cervical carcinoma[ J ]. Br J Cancer,1999,80(12) :8 - 18.
  • 5Barbashina V, Salazar P, Holland EC, et al. Allelic losses at 1 p36 and 19q13 in gliomas:correlation withhistologic classification,definition of al50-kb minimaldeleted region on 1 p36, and evaluation of camtal as a candidatetumor suppressor gene [ J ]. Clin Cancer Res, 2005,2 ( 11 ) : 1119 - 1128.
  • 6Cairncoss JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas [ J ], J Natl Cancer Inst, 1998,90 : 1473-1479.
  • 7Smith JS, Alderete B, Minn Y, et al.Localization of common deletion regions on lp and 19q in human gliomas and their association with histological subtype[ J], Oncogene, 1999,18:4144-4152.
  • 8Bigner SH, Matthews MR, Rasheed BK, et al. Molecular genetic aspects of oligoden drogliomas including analysis by comparative genomic hybridization [ J ]. Am J Pathol, 1999,155:375 -386.
  • 9Gelpi E, Ambros IM, Birner P, et al. Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1 p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens [ J ]. Mod Pathol 2003,16:708 - 715.
  • 10Ragnarsson G, Eiriksdottir G, Johannsdottir JT, et al. Loss of heterozygosity at chromosome 1 p in different solid human tumours: association with survival [ J ]. Br J Cancer, 1999,79:1468-1474.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部